首站-论文投稿智能助手
典型文献
18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs
文献摘要:
Hepatic stellate cells(HSCs)are essential drivers of fibrogenesis.Inducing activated-HSC apoptosis is a promising strategy for treating hepatic fibrosis.18beta-glycyrrhetinic acid(18β-GA)is a natural com-pound that exists widely in herbal medicines,such as Glycyrrhiza uralensis Fisch,which is used for treating multiple liver diseases,especially in Asia.In the present study,we demonstrated that 18β-GA decreased hepatic fibrosis by inducing the apoptosis in activated HSCs.18β-GA inhibited the expression of α-smooth muscle actin and collagen type Ⅰ alpha-1.Using a chemoproteomic approach derived from activity-based protein profiling,together with cellular thermal shift assay and surface plasmon reso-nance,we found that 18β-GA covalently targeted peroxiredoxin 1(PRDX1)and peroxiredoxin 2(PRDX2)proteins via binding to active cysteine residues and thereby inhibited their enzymatic activities.18β-GA induced the elevation of reactive oxygen species(ROS),resulting in the apoptosis of activated HSCs.PRDX1 knockdown also led to ROS-mediated apoptosis in activated HSCs.Collectively,our findings revealed the target proteins and molecular mechanisms of 18β-GA in ameliorating hepatic fibrosis,highlighting the future development of 18β-GA as a novel therapeutic drug for hepatic fibrosis.
文献关键词:
作者姓名:
Qian Zhang;Piao Luo;Liuhai Zheng;Jiayun Chen;Junzhe Zhang;Huan Tang;Dandan Liu;Xueling He;Qiaoli Shi;Liwei Gu;Jiahao Li;Qiuyan Guo;Chuanbin Yang;Yin Kwan Wong;Fei Xia;Jigang Wang
作者机构:
Artemisinin Research Center and Institute of Chinese Materia Medica,Chinese Academy of Chinese Medical Sciences,Beijing,100700,China;Department of Geriatrics,Shenzhen People's Hospital(The Second Clinical Medical College,Jinan University),Shenzhen,518020,China;Department of Biological Sciences,National University of Singapore,Singapore,117543,Singapore
引用格式:
[1]Qian Zhang;Piao Luo;Liuhai Zheng;Jiayun Chen;Junzhe Zhang;Huan Tang;Dandan Liu;Xueling He;Qiaoli Shi;Liwei Gu;Jiahao Li;Qiuyan Guo;Chuanbin Yang;Yin Kwan Wong;Fei Xia;Jigang Wang-.18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs)[J].药物分析学报(英文),2022(04):570-582
A类:
18beta,glycyrrhetinic,chemoproteomic
B类:
acid,induces,ROS,mediated,apoptosis,ameliorate,hepatic,fibrosis,targeting,PRDX1,activated,HSCs,Hepatic,stellate,cells,are,essential,drivers,fibrogenesis,Inducing,promising,strategy,treating,GA,natural,com,pound,that,exists,widely,herbal,medicines,such,Glycyrrhiza,uralensis,Fisch,which,used,multiple,liver,diseases,especially,Asia,present,study,we,demonstrated,decreased,inducing,inhibited,expression,smooth,muscle,actin,collagen,type,alpha,Using,approach,derived,from,activity,profiling,together,cellular,thermal,shift,assay,surface,plasmon,reso,nance,found,covalently,targeted,peroxiredoxin,PRDX2,proteins,via,binding,cysteine,residues,thereby,their,enzymatic,activities,induced,elevation,reactive,oxygen,species,resulting,knockdown,also,Collectively,our,findings,revealed,molecular,mechanisms,ameliorating,highlighting,future,development,novel,therapeutic,drug
AB值:
0.60026
相似文献
Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1α/NF-κB feedback pathway to inhibit liver fibrosis
Feixia Wang;Zhanghao Li;Li Chen;Ting Yang;Baoyu Liang;Zili Zhang;Jiangjuan Shao;Xuefen Xu;Guoping Yin;Shijun Wang;Hai Ding;Feng Zhang;Shizhong Zheng-Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica,School of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210023,China;Department of Anesthesiology,Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine,Nanjing 210003,China;College of Traditional Chinese Medicine,Shandong University of Traditional Chinese Medicine,Jinan 250035,China;Department of General Surgery,Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine,Nanjing 210003,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma
Xiao Mo;Cheng-fei Zhang;Ping Xu;Min Ding;Zhi-jie Ma;Qi Sun;Yu Liu;Hong-kai Bi;Xin Guo;Alaa Abdelatty;Chao Hu;Hao-jun Xu;Guo-ren Zhou;Yu-liang Jia;Hong-ping Xia-Sir Run Run Hospital,Nanjing Medical University,Nanjing 211166,China;School of Basic Medical Sciences&State Key Laboratory of Reproductive Medicine&Key Laboratory of Antibody Technique of National Health Commission&Jiangsu Antibody Drug Engineering Research Center,Nanjing Medical University,Nanjing 210092,China;Jiangsu Cancer Hospital&Jiangsu Institute of Cancer Research&The Affiliated Cancer Hospital of Nanjing Medical University,Nanjing 210092,China;Yijishan Hospital of Wannan Medical College,Wannan Medical College,Wuhu 241002,China
NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
Zhi-yong Xie;Wei Dong;Li Zhang;Meng-jie Wang;Zhen-meng Xiao;Yu-hua Zhang;Wan-xin Shi;Ying Huang;Yan Yang;Cui-li Li;Lei Fu;Xing-chen Zhao;Rui-zhao Li;Zhi-lian Li;Yuan-han Chen;Zhi-ming Ye;Shuang-xin Liu;Zheng Dong;Xin-ling Liang-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Division of Nephrology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;School of Medicine,South China University of Technology,Guangzhou 510006,China;Department of Cellular Biology and Anatomy,Medical College of Georgia at Augusta University,Augusta,GA,USA;Department of Medical Research,Charlie Norwood Veterans Affairs Medical Center,Augusta,GA,USA
Silibinin relieves UVB-induced apoptosis of human skin cells by inhibiting the YAP-p73 pathway
Wei-wei Liu;Fang Wang;Can Li;Xiao-yu Song;Wuxiyar Otkur;Yu-ying Zhu;Toshihiko Hayashi;Kazunori Mizuno;Shunji Hattori;Hitomi Fujisaki;Takashi Ikejima-Wuya College of Innovation,Shenyang Pharmaceutical University,Shenyang 110016,China;CAS Key Laboratory of Separation Science for Analytical Chemistry,Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China;Department of Chemistry and Life science,School of Advanced Engineering,Kogakuin University,2665-1,Nakanomachi,Hachioji,Tokyo 192-0015,Japan;Nippi Research Institute of Biomatrix,Toride,Ibaraki 302-0017,Japan;Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research&Development,Shenyang 110016,China
IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway
Shuai-xing Wang;Ye-nan Feng;Shan Feng;Ji-min Wu;Mi Zhang;Wen-li Xu;You-yi Zhang;Hai-bo Zhu;Han Xiao;Er-dan Dong-Department of Cardiology and Institute of Vascular Medicine,Peking University Third Hospital,NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides,Key Laboratory of Molecular Cardiovascular Science,Ministry of Education,Beijing Key Laboratory of Cardiovascular Receptors Research,Beijing 100191,China;State Key Laboratory for Bioactive Substances and Functions of Natural Medicines,Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells
Hao Shen;Han Yu;Qian-yu Li;Ya-ting Wei;Jing Fu;Hui Dong;Dan Cao;Lin-na Guo;Lei Chen;Yuan Yang;Ying Xu;Meng-chao Wu;Hong-yang Wang;Yao Chen-International Cooperation Laboratory on Signal Transduction,National Center for Liver Cancer,Ministry of Education Key Laboratory on signaling Regulation and Targeting Therapy of Liver Cancer,Shanghai Key Laboratory of Hepato-biliary Tumor Biology,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University/NAVAL Medical University,Shanghai 200433,China;Department of Pathology,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Institute of Metabolism and Integrative Biology,Fudan University,Shanghai 200438,China;Third Department of Hepatic Surgery,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai 200433,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。